賓度

Recent publications · Crossref

5 total works indexed

1. Global Biodiversity Scenarios for the Year 2100

   · 2000 · cited 7,136x

2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   · 2015 · cited 6,947x

3. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

   · 2017 · cited 5,481x

4. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

   · 2018 · cited 3,970x

5. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

   · 2017 · cited 3,857x

via Crossref · CC0

Wikidata facts

via Wikidata · CC0